key: cord-0751206-lxgofvye
authors: Qi, Lin; Yang, Yong; Jiang, Dixuan; Tu, Chao; Wan, Lu; Chen, Xiangyu; Li, Zhihong
title: Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: A retrospective cohort study
date: 2020-05-17
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.05.045
sha: 7df7ed7ca3361a41ec885b3cc3efc071aa0a7ed9
doc_id: 751206
cord_uid: lxgofvye

Abstract Objectives To investigate factors associated with the duration of viral shedding in patients with COVID-19 outside of Wuhan. Methods In this retrospective cohort study, patients with laboratory-confirmed COVID-19 in Changsha, China were included. Clinical characteristics, laboratory findings, treatment and outcome were retrieved. Univariable and multivariable analysis were performed to explore potential factors. Results Totally 147 patients with COVID-19 were included. The median duration of viral shedding (the number of days from symptoms onset till the successive negative detection of SARS-CoV-2 RNA) was 17 days (interquartile range [IQR], 12 to 21). Multivariable Logistic regression analysis indicated that the highest temperature at admission (odds ratio [OR], 5.200; 95% confidence interval [CI]: 1.190-22.726; p = 0.028) and time from symptom onset to admission (OR, 1.740; 95% CI: 1.296-2.337; p < 0.001) and hospital length of stay (OR, 1.604; 95% CI: 1.262-2.040; p < 0.001) were risk factors for prolonged duration of viral shedding. Conclusions This is the study with relatively large sample size that mainly focused on the duration of viral shedding and relevant factors in patients with COVID-19 outside of Wuhan, China. Potential risk factors were identified and should be taken into consideration for the strategy of quarantine of infected patients.

The outbreak of COVID-19 in December 2019, Wuhan, China has become a public health emergency of international concern (PHEIC) due to the ability of human-tohuman transmission (Arshad Ali et al., 2020) . As of May 11, 2020, totally 84450 cases have been diagnosed with COVID-19 in China and 4644 deaths have been confirmed. Most patients with COVID-19 have mild clinical symptoms, while a small portion of them developed severe complications including acute respiratory distress syndrome (ARDS), acute kidney injury (AKI) and multiple organ dysfunction syndrome (MODS) , which usually lead to worse prognosis , Xu Xiao-Wei et al., 2020 , Yang Xiaobo et al., 2020 . It was reported that mortality of adults with COVID-19 in Wuhan was associated with older age, high sequential organ failure assessment (SOFA) score and d-dimer more than 1 μg/L . Of interest, the mortality rate of COVID-19 outside Wuhan was much lower than that of patients in Wuhan (Tian et al., 2020 .

Changsha is capital of Hunan province with permanent population of 8.15 million.

Hunan province is adjacent to Hubei province, and Changsha is only 300 kilometers from Wuhan as the crow flies. The geographic advantages may allow easier transmission of COVID-19 with the cumulative confirmed cases of 242 in Changsha by March 14 th , 2020. The majority of current published studies mainly concerned about Wuhan in Hubei province, China, while few shed light on patients with COVID-19 in imported cities , Shi et al., 2020 , Yang Xiaobo et al., 2020 , Zhang et al., 2020 .

Besides, the duration of viral shedding is a potential indicator concerning the J o u r n a l P r e -p r o o f infectivity and transmissibility of epidemic diseases (Ryoo et al., 2013) . However, the duration of viral shedding in adults with COVID-19 outside Wuhan and potential related factors haven't been well explored, which is also one of significant criteria for discharge . Therefore, utilizing the date of patients with COVID-19 from Changsha public health treatment center, the aims of this study were to describe the clinical characteristics of patients with COVID-19 in Changsha and analyze the factors associated with the duration of viral shedding.

This retrospective, single-center cohort study included patients with COVID-19 from Changsha public health treatment center, the branch of the first hospital of Changsha that is the only appointed medical institution for the treatment of patients with COVID-19 in Changsha. Patients were diagnosed with COVID-19 based on the guidelines released by National Health Commission of the People's Republic of China (Lin L, 2020) . This study was conducted following Declaration of Helsinki. The study was approved by the institutional research ethics committee of Second Xiangya hospital (No.2020[017] ). Due to this emergency public health event, the written informed consents were waived and patients included in this study were given oral consents.

J o u r n a l P r e -p r o o f From January 24 th to March 8 th , 2020, all patients diagnosed with COVID-19 in Changsha public health treatment center were screened. The specific inclusive criteria were as follows: (1) patients confirmed by positive detection of SARS-CoV-2 RNA of nasopharyngeal/throat swabs by real-time reverse transcription-polymerase chain reaction (RT-PCR); (2) patients aged more than 18 years old; (3) patients with known date of performing different RT-PCR assays. The screening was up to March 14 th ， the final follow-up.

Demographic and clinical characteristics, laboratory findings, radiography, treatment and outcome were retrieved from the electronic medical records. Exposure history was defined as having exposure to people diagnosed with COVID-19. The confirmation of COVID-19 was based on RT-PCR assays from different institutions including Changsha public health treatment center and Chinese center for disease control and prevention (CDC). During hospitalization, another RT-PCR assay would be immediately conducted every other day after the remission of clinical symptoms or radiography of patients, and corresponding date was recorded. The duration of viral shedding was defined as the number of days from the symptoms onset till the successive negative detection of SARS-CoV-2 RNA, which was consistent with the studies of COVID-19 (Xu K. et al., 2020 . Fever was defined as the axillary temperature ≥37.3℃. The clinical classification of COVID-19 was based on J o u r n a l P r e -p r o o f the guideline (Lin L, 2020) . The moderate type was defined as patient with fever, respiratory tract symptoms and imaging characteristics of confirmed pneumonia.

Severe type was defined as patients with any conditions including respiratory distress (respiratory rate ≥ 30 times/min), fingertip oxygen saturation ≤93% in the resting state and partial pressure of oxygen /fraction of inspired oxygen ≤300 mmHg. Critical type was defined as patients with any conditions including respiratory failure needing mechanical ventilation, shock and any organ failure needing intensive care unit (ICU) admission. Laboratory examination and radiography of patients with COVID-19 at the initial admission were extracted. The discharge criteria were composed of the absence of fever for over 3 days, significant remission of respiratory tract symptoms and radiography of lungs and two continuous negative detections of SARS-CoV-2 RNA from nasopharyngeal/throat swabs by RT-PCR at the time interval of over 24 hours.

All data extraction was conducted independently by two researchers, and another researcher would be invited to check out if there was any difference between first two researchers.

The primers and probes were designed to target ORF1ab and N genes based on the guideline of Chinese CDC. The cycle threshold (Ct) value is a quantitative indicator of viral load (Young et al., 2020) . The Ct value of ORF1ab less than 40 were J o u r n a l P r e -p r o o f 8 / 30 considered as the positive test results in this study.

Continuous variables were presented as the median and IQR. Categorical variables were described as frequency and percentage. Kaplan-Meier survival analysis was introduced to estimate the cumulative SARS-CoV-2 RNA-negativity rate. The patients were divided into two separate groups based on the median of duration of viral shedding of all patient included. Mann-Whitney U test was introduced to compare the differences between two groups for quantitative variables. We also conducted Pearson's chi-squared test or Fisher's exact test for categorical variables to assess different characteristics in two groups. Multivariable logistic regression was applied to figure out potential factors associated with the duration of viral shedding. The receiver Operating Characteristic (ROC) curve was introduced to evaluate the potential of the multivariable logistic regression model. Corresponding area under curve (AUC) was also calculated. All statistical analyses were conducted utilizing SPSS version 24 for Windows (IBM, Armonk, New York, USA). The figure illustrating dynamics of the viral load in patients since onset of symptoms was generated by GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA). Twosided P<0.05 was defined as statistical significance.

A total of 164 patients with laboratory-confirmed COVID-19 in Changsha public health treatment center were screened out. There was no specific data concerning the duration of viral shedding in 15 patients, and 2 patients aged under 18 years old.

Finally, totally 147 patients were included in the current study. The demographic and clinical characteristics of 147 patients were presented in Table 1 . Among these patients, the median age was 42 years old (IQR, 35 to 54). The percentage of female gender (54%, 80/147) was slightly higher than that of male gender (46%, 67/147).

The median body mass index (BMI) was 23.2 (IQR, 21.3 to 25.6). There were 73 patients who had exposure to people diagnosed with COVID-19 before admission.

Patients associated with familial cluster made up the majority of study population (77%, 113/147). Nearly 20% of patients (30/147) had at least one comorbidity. The most common symptoms included fever (78%, 115/147) and cough (83%, 122/147).

Fatigue was also relatively common in patients included (42%, 62/147). The median time interval from symptom onset to admission was 6 days (IQR, 3 to 10). According to the clinical classification of the guideline, 127 patients with COVID-19 were categorized into the group of moderate type while 14% (20/147) were categorized into the group of severe type.

The median duration of viral shedding in the current study was 17 days (IQR, 12 to 21). The shortest and longest durations were 6 days and 47 days, respectively. The cumulative proportion of patients with detectable SARS-CoV-2 RNA was presented in Table S1 and Figure S1 . It was noted that the proportion declined to 50% about 17 J o u r n a l P r e -p r o o f days after symptoms onset. Based on the median as the cut-off point, the study population were further divided into two groups with duration of viral shedding of more than 17 days (n=65) and less than 17 days (n=82). The prolonged duration of viral shedding was defined as the duration more than 17 days. There was no significant difference in distribution of age and sex, BMI, exposure history and comorbidities between two groups of duration in the univariable analysis ( Table 1) .

The percentage of patients with hemoptysis was significantly higher in the group of prolonged duration of viral shedding (p=0.015). There was also significant difference in the highest temperature between two groups (p=0.049), with the median highest temperature of 38.3℃ in the group of prolonged duration. Of note, patients with prolonged duration had significantly longer time from symptom onset to admission (p<0.001).

All laboratory findings of patients at the initial admission were presented in Table 2 .

Only 61 of 147 patients had specific Ct values. And specific Ct values of these 61 patients with COVID-19 were obtained in this study. The initial Ct values in patients with prolonged duration of viral shedding was lower than that in patients with duration less than 17 days. The dynamics of the viral load in relation to the days since onset of symptoms in 61 patients were presented in Figure 1 . For patients with the duration of viral shedding less than 17 days, the viral load was undetectable for half patients (15/30) after 12 days since the onset of symptoms ( Figure 1A ). However, for J o u r n a l P r e -p r o o f patients with prolonged duration of viral shedding more than 17 days, the viral load was undetectable for nearly half patients (16/31) after 22 days since the onset of symptoms ( Figure 1B ). On admission, nearly 79% of patients with COVID-19 (115/147) obtained abnormal results of blood gas analysis with PH more than 7.45.

The PaO2 of 5 patients was below 60 mmHg while the partial pressure of carbon dioxide (PaCO2) of 1 patient was over 50 mmHg. The results of blood gas analysis showed that the level of PaO2 was lower in patients with prolonged duration of viral shedding (P=0.034). About 37% of patients (54/147) developed leucopenia (white blood cell count＜4.0×10 9 /L) and 23% of patients (34/147) All patients with COVID-19 received chest radiography in the initial admission.

Abnormal signs of chest radiography were detected within all patients expect for 6 of J o u r n a l P r e -p r o o f them. The chest radiography of most patients (85%, 124/147) suggested bilateral involvement of lungs. No obvious difference in chest radiography was noted between these two groups of duration.

During hospitalization, all the patients with COVID-19 received antiviral treatment (Table 3 ). The protocol of antiviral treatment was based on the official guideline with ribavirin and interferon most commonly used. Nearly 47% (64/147) of patients received antibiotic treatment. Glucocorticoids and immunoglobulin were used in 39 and 37 patients, respectively. Among patients with the treatment including antibiotics, glucocorticoids and immunoglobulin, the percentage of the group of prolonged duration was higher than that in the group of duration of viral shedding less than 17 days. The majority of patients with COVID-19 (94%, 138/147) received respiratory supports by the nasal cannula. High flow nasal cannula was only used in a small number of patients (3%, 5/147), and no significant difference was noted in the treatment of respiratory support between two groups. There was only one patient treated with non-invasive ventilation in this study. In the current study, no patient with COVID-19 received advanced respiratory supports including mechanical ventilation and extracorporeal membrane oxygenation (ECMO). There were very few patients developing relatively serious complications including ARDS, AKI and MODS during admission. As of March 19 th , 2020, all the patients in this study have been cured and discharged from hospital. The follow-up survey of discharged patients was conducted J o u r n a l P r e -p r o o f mainly through periodic outpatient visits. Discharged patients were asked to visit the special out-patient clinic every week after discharge. In the special out-patient clinic, RT-PCR assays and radiography were performed accordingly. And none of patients were found changed from negative to positive by RT-PCR assays after hospital discharge.

Factors that were statistically significant in the univariable analysis were further entered into the multivariable Logistic regression analysis. As presented in Table 4 , the multivariable Logistic regression analysis suggested that the highest temperature at admission (OR, 5.200; p=0.028) , time from symptom onset to admission (OR, 1.740; 95% CI: 1.296-2.337; p<0.001) and hospital length of stay (OR, 1.604; 95% CI: 1.262-2.040; p<0.001) remained statistically significant in the final multivariable Logistic regression analysis, which served as risk factors for prolonged duration of viral shedding of more than 17 days. The ROC curve was further generated to evaluate the potential of the final multivariable Logistic regression model. As was illustrated in Figure 2 , the ROC curve indicated optimal predictive capability (AUC=0.935, 95%CI: 0.861-0.977).

In the current study, we retrieved data of totally 147 patients with laboratoryconfirmed COVID-19. The clinical characteristics were described, and factors J o u r n a l P r e -p r o o f associated with duration of viral shedding of COVID-19 were analyzed. Risk factors for the prolonged duration of viral shedding were identified, including the highest temperature at admission, time from symptom onset to admission and hospital length of stay.

In influenza virus infections, it was reported that the duration of viral shedding was related to infectivity and transmissibility, serving as the significant factor of infection prevention and control (Ryoo et al., 2013) . Therefore, it is of great significance to explore the duration of viral shedding and related factors in patients with COVID-19.

The median duration of viral shedding in the current study was 17 days, which was close to that in a recent study conducted in Wuhan . There were totally 191 patients in Wuhan with median duration of viral shedding of 20 days included in that study, while 54 of them died during hospitalization. The minor difference in the duration of viral shedding between these two studies was probably based on the condition of patients, as the patients with severe type of COVID-19 only made up a minor part in the current study. However, so far there is no official definition of the prolonged duration of viral shedding in COVID-19. In this study, the cut-off value was defined as the median of the duration of viral shedding. The same method of choosing the median of viral shedding as the cut-off value could also be found in one high-quality study concerning COVID-19, in which the cut-off value was close to that in our study (Xu K. et al., 2020) .

The middle-aged patients made up the majority of the study population. Although the patients with prolonged duration of viral shedding were slightly older, no significant difference was noted concerning the age between two groups with different durations of vial shedding. Advanced age was reported to be significantly associated with prolonged duration of viral RNA detection in patients with influenza A (H3N2) (Lee et al., 2009) . Recent studies about the patients with COVID-19 also suggested that older age might be a potential significant predictor for severity and mortality (Zhang et al., 2020 . Older patients were more likely to develop severe comorbidities, which usually lead to worse prognosis compared with young patients.

However, the percentage of patients with comorbidities and severe type of COVID-19 was relatively lower in the current study, and the effect of age on the duration of viral shedding in patients with COVID-19 still needs further study. Fever and cough were the most common symptoms of patients in the current study, which was consistent with previous studies with large sample size (Guan et al., 2020) . Of note, the highest temperature of patients was significantly associated with prolonged duration of viral shedding in this study. Body temperature is one of vital signs to assess the patient's condition. In influenza A virus infections, there was a positive correlation between the tympanic temperature and vial shedding (Lau et al., 2010) . One recent study also reported that the highest temperature at admission was the risk factor for the progression of COVID-19 . Therefore, patients with higher temperature at admission are supposed to be closely monitored and quarantined for longer time. The longest duration of viral shedding of patients in the current study J o u r n a l P r e -p r o o f was 47 days. The 40-year-old male who had symptoms in January 4 th and was diagnosed with COVID-19 based on RT-PCR assays in January 12 th . He was admitted to the appointed medical institution in February 14 th and was found the detection of SARS-CoV-2 RNA changed 6 days later. As suggested in the current study, it may take longer time for patients with prolonged duration of viral shedding to get admitted to hospital after symptoms onset. The decreased time from symptoms onset to admission allowed prompt treatment, which was probably associated with the duration of viral shedding. Of note, in the early stage of clinical work in our center, respiratory tract specimens including nasopharyngeal swab specimens, oropharyngeal swab specimens and sputum specimens of patients were obtained. For nasopharyngeal swabs, the depth of collecting specimen is the key factor while this procedure seems more acceptable with relatively low exposure risk. However, in the practical clinical work in our center, we found that collecting nasopharyngeal swabs might generate relatively high false-negative detection results. Besides, there is no firm evidence concerning the superiority of collecting nasopharyngeal swabs in COVID-19. Therefore, we mainly collected throat (oropharyngeal) swabs in subsequent clinical work.

Specific Ct values of 61 patients were retrieved in this study. Although the initial Ct values in patients with prolonged duration of viral shedding was lower, no statistically significant difference was noted between two groups of different duration. It was reported that viral shedding of most patients with COVID-19 was high in the early J o u r n a l P r e -p r o o f stage since onset of symptoms (Wolfel et al., 2020) . Besides, severity of patients with COVID-19 was probably associated with lower Ct values (Zou et al., 2020) . In the current study, it was also noted that the Ct values of patients increased with the improvement of symptoms. For the results of blood gas analysis, the level of PaO2 was significantly lower in the patient with the prolonged duration of viral shedding.

The level of PaO2 is the index reflecting arterial oxygenation while the role in the duration of viral shedding in COVID-19 still needs further study (Collins et al., 2015) .

The percentage of patients with lymphopenia was much lower than that in a previous study, in which 75.4% of patients presented lymphopenia (Zhang et al., 2020) . It was also noted that the patients with severe type accounted for a relatively large part in that study. The level of inflammatory indicators including c-reactive protein and procalcitonin were similar in two groups with different durations of viral shedding.

More than half of patients had abnormal range of serum ferritin, and serum ferritin significantly elevated in the patients with prolonged duration of viral shedding. For chest radiography, most patients with COVID-19 presented bilateral involvement of lungs, which was also consistent with previous studies , Zhang et al., 2020 .

All the patients with COVID-19 in Changsha public health treatment center received antiviral treatment. In recent studies concerning COVID-19 in Wuhan, the percentage of patient with antiviral treatment was much lower than that in the current study . Before COVID-19 outbroke, Changsha public health treatment center was the appointed medical institution for patients infected with the human immunodeficiency virus (HIV). Therefore, antiviral treatment was more likely to be administered promptly as the routine treatment. However, it remained relatively unknown whether the antiviral treatment would shorten the duration of viral shedding as all patients treated with antiviral treatment. Besides, it was reported that lopinavir-ritonavir treatment didn't work effectively in patients with severe type in the recent study . Patients with prolonged duration of viral shedding tended to receive antibiotics, glucocorticoids and immunoglobulin in the current study. The antibiotics may cover common spectrum of pathogens but the use of glucocorticoids in viral pneumonia remained controversial (Russell et al., 2020 , Yang Xiaobo et al., 2020 . Several mild complications were observed and treated promptly. The length of hospital stays in patient with prolonged duration of viral shedding was much longer as the two continuous negative detections of SARS-CoV-2 RNA over 24 hours was one of significant criteria for discharge (Lin L, 2020 , Yang Xiaobo et al., 2020 .

A recent study also focused on the viral shedding in patients with COVID-19 in Qingddao, China . Of note, there were some differences between these two studies. The novel definition called the communicable period was introduced in that study, which was defined as the duration from the first positive detection to the first successive negative detection of SARS-CoV-2 RNA. The median communicable period in that study was 14 days, which was close to the median J o u r n a l P r e -p r o o f duration of viral shedding in our study. The slight difference of duration may come from the different starting points in the definitions. In general, the onset of symptoms was earlier than collecting specimens of patients. Besides, the definition of the duration of viral shedding was also consistent with that in one high-quality study of COVID-19 in Hangzhou, in which the median of duration of viral shedding was also 17 days (IQR, 13-22 days) (Xu K. et al., 2020) . The study in Qingdao with 59 patients indicated that prolonged communicable period was associated with older age and There are some limitations concerning the design and data in the present study. First, demographic and clinical characteristics, laboratory findings and radiography were incomplete because of the retrospective study design. Second, the sample size in the single center outside Wuhan remained relatively small and most patients included in this study had mild clinical symptoms. Third, specimens of the respiratory tract including sputum, nasopharyngeal swab and oropharyngeal swab specimens were collected in this study, most of which were throat (oropharyngeal) swab specimens.

And some study reported that prolonged presence of viral RNA could be found in faecal samples . Specific viral load of 61 patients were obtained in this study, which represented relatively large sample size compared with some highquality study of COVID-19 (Young et al., 2020) . However, the viral load of the patient with longest duration of 47 days wasn't included because of the lack of corresponding Ct value. We couldn't further explore relevant factors due to the lack of specific data in some values.

To the best of our knowledge, this is the study with relatively large sample size that mainly focused on the duration of viral shedding and relevant factors in patients with COVID-19 outside of Wuhan, China. We found that the highest temperature at admission, time from symptom onset to admission and hospital length of stay were risk factors for the prolonged duration of viral shedding, which should be taken into consideration for the strategy of quarantine of infected patients. Multi-center study with large sample size is needed to further explore factors associated with duration of viral shedding in adults with COVID-19. J o u r n a l P r e -p r o o f 

The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat

A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Relating oxygen partial pressure, saturation and content: the haemoglobin-oxygen dissociation curve

Clinical Characteristics of Coronavirus Disease 2019 in China

Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19

Viral shedding and clinical illness in naturally acquired influenza virus infections

Viral loads and duration of viral shedding in adult patients hospitalized with influenza

Interpretation of Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection by the National Health Commission (Trial Version 5)

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

The value of early transmission dynamic studies in emerging infectious diseases. The Lancet Infectious Diseases

COVID-19 and Italy: what next? The Lancet

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious Diseases

Covid-19: cases grow in US as Trump pushes promise of a malaria drug

Characteristics of COVID-19 infection in Beijing

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Virological assessment patients with COVID-2019

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Factors associated with prolonged viral RNA shedding in patients with COVID-19

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

The authors would like to their gratitude to the patients and the medical affairs staff in this study. This work was supported by grants from the National Natural Science 

Duration of viral shedding a Abbreviation: COVID-19, coronavirus disease 2019; NA, not applicable; ECMO, extracorporeal membrane oxygenation; ARDS, acute respiratory distress syndrome; AKI, acute kidney injury; MODS, multiple organ dysfunction syndrome.